搜索临床试验以:大剂量芦可替尼
总计11338个结果
-
Jiangsu Province Centers for Disease Control and...Academy of Military Medical Sciences,Academy of Military Sciences,PLA; ZHONGYIANKE Biotech Co... 和其他合作者招聘中
-
Novartis Pharmaceuticals终止具有高分子风险突变的骨髓纤维化比利时, 西班牙, 英国, 匈牙利, 意大利, 日本, 台湾, 德国, 加拿大, 新加坡, 奥地利, 澳大利亚, 法国, 以色列, 瑞典, 瑞士, 香港, 希腊, 火鸡, 巴西, 俄罗斯联邦, 丹麦, 葡萄牙, 挪威, 波兰
-
John MascarenhasNational Cancer Institute (NCI); Novartis; Incyte Corporation; Myeloproliferative Disorders-Research...终止
-
Azienda USL Toscana Nord OvestAzienda Ospedaliero, Universitaria Pisana; Azienda Ospedaliera Universitaria Senese; Fondazione...未知严重急性呼吸系统综合症冠状病毒 2
-
Julie NangiaIncyte Corporation; Translational Breast Cancer Research Consortium招聘中
-
University of South CarolinaMedical University of South Carolina; National Institute on Deafness and Other Communication...完全的
-
Institute of Hematology & Blood Diseases Hospital尚未招聘鲁索替尼对 AA HSCT 受者的 aGVHD 的预防价值
-
Memorial Sloan Kettering Cancer CenterIncyte Corporation; Hackensack Meridian Health完全的
-
National Institute of Arthritis and Musculoskeletal...终止
-
Universidade Federal do vale do São FranciscoConselho Nacional de Desenvolvimento Científico e Tecnológico招聘中
-
Keros Therapeutics, Inc.IQVIA Biotech招聘中
-
University Hospital Inselspital, Berne招聘中青光眼 | 黄斑变性 | 葡萄膜炎 | 糖尿病性视网膜病变 | 糖尿病性黄斑水肿 | 黄斑水肿 | 视网膜静脉阻塞 | 视神经疾病 | 视网膜脱离 | 黄斑部疾病 | 视网膜疾病 | 视网膜新生血管 | 视网膜动脉阻塞 | 高血压性视网膜病变 | 视网膜水肿 | 视网膜营养不良瑞士
-
Incyte Corporation完全的
-
Carmel Medical CenterTechnion, Israel Institute of Technology完全的
-
Carmel Medical CenterTechnion, Israel Institute of Technology完全的
-
University of the West of EnglandUniversity of Hawaii; Indonesia University; Unilever R&D; UNICEF完全的
-
University of PittsburghPatient-Centered Outcomes Research Institute招聘中
-
University of Southern CaliforniaNational Institutes of Health (NIH)撤销